Back to top

Iradimed (IRMD) Achieves Record Q2 Revenue with Strong Growth Prospects

Iradimed (IRMD) Achieves Record Q2 Revenue with Strong Growth Prospects

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

iRadimed Corporation (IRMD)